- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
CTO revascularization improves total myocardial viability: Study
Netherlands: Chronic total occlusion (CTO) revascularization increases remote myocardial perfusion, a recent study has shown. The biggest gains were observed in patients having significant improvements in various blood flow measures. This indicates that "CTO percutaneous coronary intervention (PCI) may have a favorable physiologic impact beyond the intended treated myocardium," the researchers wrote. The study appears in the journal EuroIntervention.
CTO revascularization is known to impact the coronary physiology of the remote myocardial territory. Ruben W. de Winter, Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands, and colleagues aimed to evaluate the intrinsic effect of CTO PCI on changes in absolute perfusion in remote myocardium.
The study included a total of 164 patients who underwent serial [15O]H2O positron emission tomography (PET) perfusion imaging at baseline and three months after successful single-vessel CTO PCI. They were evaluated for changes in coronary flow reserve (CFR) and hyperaemic myocardial blood flow (hMBF) in remote myocardium supplied by both non-target coronary arteries.
Key findings include:
- Perfusion indices in CTO and remote myocardium showed a positive correlation before (resting MBF: r=0.84, hMBF: r=0.75, and CFR: r=0.77) and after (resting MBF: r=0.87, hMBF: r=0.87, and CFR: r=0.81) CTO PCI.
- Absolute increases in hMBF and CFR were observed in remote myocardium following CTO revascularisation (from 2.29±0.67 to 2.48±0.75 mL·min–1·g–1 and from 2.48±0.76 to 2.74±0.85, respectively).
- Improvements in remote myocardial perfusion were largest in patients with a higher increase in hMBF (β 0.58) and CFR (β 0.54) in the CTO territory, independent of clinical, angiographic, and procedural characteristics.
"CTO revascularization resulted in an increase in remote myocardial perfusion. The quantitative improvement in hMBF and CFR in the CTO territory was found to be independently associated with the absolute perfusion increase in remote myocardial regions," wrote the authors.
As such, CTO PCI may have a favorable physiologic impact beyond the intended treated myocardium, they noted.
Reference:
The study titled, "Impact of percutaneous coronary intervention of chronic total occlusions on absolute perfusion in remote myocardium," was published in the journal EuroIntervention.
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751